Model Number FR995-25 |
Device Problems
Off-Label Use (1494); Improper or Incorrect Procedure or Method (2017); Insufficient Information (3190); Material Split, Cut or Torn (4008)
|
Patient Problems
Hemorrhage/Bleeding (1888); Blood Loss (2597); No Code Available (3191)
|
Event Date 06/05/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that during the initial implant of this bioprosthetic valve and after being fully sutured into place, there was a tear in the proximal skirt which resulted in bleeding near the septal muscle.As a result, the valve was explanted and another valve was successfully implanted in its place.No additional adverse patient effects were reported. .
|
|
Manufacturer Narrative
|
Description of event updated.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that during the initial implant of this bioprosthetic valve and after being fully sutured into place, there was a tear in the proximal skirt which resulted in bleeding near the septal muscle.As a result, the valve was explanted and another valve was successfully implanted in its place.This led to an extended time on bypass, and post operative, renal insufficiency was identified that led to a prolonged stay in the intensive care unit (icu).No additional adverse patient effects were reported. .
|
|
Manufacturer Narrative
|
Product analysis: upon receipt at medtronic¿s quality laboratory, visual examination revealed that the myocardial tissue was torn at approximately 1cm in length, along the inflow margin of attachment in the left right inferior coaptive area.The stitching line was intact, however the affected sewing ring was everted.The stitches were removed which revealed tissue under the cloth above the stitching line.All leaflets were in the open position and were flexible and intact.All commissures were intact.There were 2 modifications made to the aortic wall.Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Per the valve instructions for use (ifu) in the ¿device implantation¿ section states ¿take care not to evert (roll outward) the inflow end of the bioprosthesis when suturing the valve to the patient¿s annulus.Eversion could damage the valve tissue.¿ and in section 5.0 ¿caution: do not invert the bioprosthesis when suturing.Inversion may result in elongated suture holes, tears, and/or distortion leading to stenosis and incompetence.¿ based on the received information and the returned product analysis, the probable cause of the torn myocardium tissue was due to the user everting the inflow sewing ring during implantation.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|